Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kelsey Maddison"'
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Glioblastoma, the most common primary malignant brain tumour in adults, is a highly vascular tumour characterised by abnormal angiogenesis. Additional mechanisms of tumour vascularisation have also been reported in glioblastoma, i
Externí odkaz:
https://doaj.org/article/2ff4fbfd4ec1442f94f89f5cf0b84df5
Autor:
Kelsey Maddison, Moira C. Graves, Sam Faulkner, Michael Fay, Paul A. Tooney, Nikola A. Bowden, Ricardo E. Vilain
Publikováno v:
Oncotarget
Immunotherapies targeting tumour-infiltrating lymphocytes (TILs) that express the immune checkpoint molecule programmed cell death-1 (PD-1) have shown promise in preclinical glioblastoma models but have had limited success in clinical trials. To asse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfdd444b988d59d0a41e97ef4f12a8bd
https://doi.org/10.18632/oncotarget.28069
https://doi.org/10.18632/oncotarget.28069
Autor:
Ricardo Vilain, Paul A. Tooney, Kelsey Maddison, Nikola A. Bowden, Michael Fay, Moira C. Graves
Publikováno v:
Neuro Oncol
Immunotherapy has been shown to have benefit in some solid tumours including melanoma where immune infiltration can be pronounced. Until recently the central nervous system was thought to be immune privileged. Whilst research has shown that immune ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::726bb2d41bb8ca91bdc6a34a2fb9ee18
https://doi.org/10.1093/neuonc/noz175.543
https://doi.org/10.1093/neuonc/noz175.543